98 related articles for article (PubMed ID: 20226854)
1. The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells.
Garate M; Wani AA; Li G
Free Radic Biol Med; 2010 Jun; 48(12):1601-9. PubMed ID: 20226854
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration.
Gao K; Dai DL; Martinka M; Li G
Cancer Res; 2006 Sep; 66(17):8382-8. PubMed ID: 16951147
[TBL] [Abstract][Full Text] [Related]
3. The expression of NAD(P)H:quinone oxidoreductase 1 is increased along with NF-kappaB p105/p50 in human cutaneous melanomas.
Cheng Y; Li J; Martinka M; Li G
Oncol Rep; 2010 Apr; 23(4):973-9. PubMed ID: 20204281
[TBL] [Abstract][Full Text] [Related]
4. Impact of NAD(P)H:quinone oxidoreductase-1 on pigmentation.
Choi TY; Sohn KC; Kim JH; Kim SM; Kim CH; Hwang JS; Lee JH; Kim CD; Yoon TJ
J Invest Dermatol; 2010 Mar; 130(3):784-92. PubMed ID: 19759547
[TBL] [Abstract][Full Text] [Related]
5. Evidence for NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated quinone-dependent redox cycling via plasma membrane electron transport: A sensitive cellular assay for NQO1.
Tan AS; Berridge MV
Free Radic Biol Med; 2010 Feb; 48(3):421-9. PubMed ID: 19932748
[TBL] [Abstract][Full Text] [Related]
6. Role of NAD(P)H:quinone oxidoreductase 1 on tumor necrosis factor-alpha-induced migration of human vascular smooth muscle cells.
Lee SO; Chang YC; Whang K; Kim CH; Lee IS
Cardiovasc Res; 2007 Nov; 76(2):331-9. PubMed ID: 17669387
[TBL] [Abstract][Full Text] [Related]
7. NQO1 prevents radiation-induced aneuploidy by interacting with Aurora-A.
Park MT; Oh ET; Song MJ; Lee H; Choi EK; Park HJ
Carcinogenesis; 2013 Nov; 34(11):2470-85. PubMed ID: 23803694
[TBL] [Abstract][Full Text] [Related]
8. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori-induced H,K-ATPase alpha-subunit gene repression is mediated by NF-kappaB p50 homodimer promoter binding.
Saha A; Hammond CE; Trojanowska M; Smolka AJ
Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G795-807. PubMed ID: 18202112
[TBL] [Abstract][Full Text] [Related]
10. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
[TBL] [Abstract][Full Text] [Related]
11. NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors.
Han Y; Shen H; Carr BI; Wipf P; Lazo JS; Pan SS
J Pharmacol Exp Ther; 2004 Apr; 309(1):64-70. PubMed ID: 14718602
[TBL] [Abstract][Full Text] [Related]
12. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
Winski SL; Hargreaves RH; Butler J; Ross D
Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
[TBL] [Abstract][Full Text] [Related]
13. Cooperation of NAD(P)H:quinone oxidoreductase 1 and UDP-glucuronosyltransferases reduces menadione cytotoxicity in HEK293 cells.
Nishiyama T; Izawa T; Usami M; Ohnuma T; Ogura K; Hiratsuka A
Biochem Biophys Res Commun; 2010 Apr; 394(3):459-63. PubMed ID: 20035715
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of NQO1 protects human SK-N-MC neuroblastoma cells against dopamine-induced cell death.
Zafar KS; Inayat-Hussain SH; Siegel D; Bao A; Shieh B; Ross D
Toxicol Lett; 2006 Oct; 166(3):261-7. PubMed ID: 16978807
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
Martins I; Sylla K; Deshayes F; Lauriol J; Ghislin S; Dieu-Nosjean MC; Viguier M; Verola O; Charron D; Alcaide-Loridan C; Al-Daccak R
Melanoma Res; 2009 Aug; 19(4):226-37. PubMed ID: 19574933
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis.
Long DJ; Waikel RL; Wang XJ; Perlaky L; Roop DR; Jaiswal AK
Cancer Res; 2000 Nov; 60(21):5913-5. PubMed ID: 11085502
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.
Siegel D; Franklin WA; Ross D
Clin Cancer Res; 1998 Sep; 4(9):2065-70. PubMed ID: 9748120
[TBL] [Abstract][Full Text] [Related]
18. Increased tumor necrosis factor-alpha sensitivity of MCF-7 cells transfected with NAD(P)H:quinone reductase.
Siemankowski LM; Morreale J; Butts BD; Briehl MM
Cancer Res; 2000 Jul; 60(13):3638-44. PubMed ID: 10910079
[TBL] [Abstract][Full Text] [Related]
19. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger.
Siegel D; Gustafson DL; Dehn DL; Han JY; Boonchoong P; Berliner LJ; Ross D
Mol Pharmacol; 2004 May; 65(5):1238-47. PubMed ID: 15102952
[TBL] [Abstract][Full Text] [Related]
20. The effect of antisense tyrosinase-related protein 1 on melanocytes and malignant melanoma cells.
Li CY; Gao TW; Wang G; Han ZY; Shen Z; Li TH; Liu YF
Br J Dermatol; 2004 Jun; 150(6):1081-90. PubMed ID: 15214892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
